Roper Technologies, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$297.40M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ROP stock price vs TMO: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TMO's multiple
Needs TMO P/E.
Implied fair value · at ROP's multiple
Needs ROP P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ROPER TECHNOLOGIES, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
THERMO FISHER SCIENTIFIC INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HONEYWELL INTERNATIONAL INC
ROP vs HON
EMERSON ELECTRIC CO
ROP vs EMR
Fortive Corp
ROP vs FTV
Keysight Technologies, Inc.
ROP vs KEYS
METTLER TOLEDO INTERNATIONAL INC/
ROP vs MTD
Vontier Corp
ROP vs VNT
Agilent Technologies, Inc.
ROP vs A
DANAHER CORP /DE/
ROP vs DHR
Illumina, Inc.
ROP vs ILMN
BRUKER CORP
ROP vs BRKR
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ROP can sustain its double-digit revenue growth while keeping margins near current levels, then the stock looks worth owning on a relative basis because its P/E discount to TMO is supported by superior margin profile and faster growth.
ROP trades below TMO-implied P/E valuation at $402.25 versus $475.47, implying 18.2% upside, and it sits below the midpoint of TMO range. However, the stock is also above the DCF range and near the upper end of the historical band, so the valuation signal is mixed rather than decisively cheap.
Supporting Metrics